SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-18-014357
Filing Date
2018-12-28
Accepted
2018-12-28 16:11:31
Documents
2
Period of Report
2018-12-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT cbmg_8k.htm 8-K 30424
2 TOLL MANUFACTURING AND SUPPLY AGREEMENT, DATED DECEMBER 21, 2018 cbmg_ex101.htm EX-10.1 599023
  Complete submission text file 0001654954-18-014357.txt   630736
Mailing Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105
Business Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105 (408) 973-7884
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36498 | Film No.: 181257543
SIC: 2836 Biological Products, (No Diagnostic Substances)